The latest in-vitro evidence of Prontosan®
Professor Adam Junka from Wroclaw Medical University, Poland presents a video on past and new in-vitro studies he has conducted on Prontosan®. The results of the in-vitro evidence show high antibiofilm activity of polyhexanide based antiseptics and lack or weak antibiofilm activity of hypochlorite-based antiseptic of total chlorine content equal to 80 parts per million.
Is your wound irrigation solution effective against biofilm?
Chronic wounds complicated with biofilm formed by pathogens remain one of the most significant challenges of contemporary medicine. The following video compares the activity of polyhexanide-, octenidine- and hypochlorite/hypochlorous acid-based antiseptics against biofilm formed by clinical strains of Candida albicans, Staphylococcus aureus and Pseudomonas aeruginosa.
Professor Adam Junka from Wroclaw Medical University, Poland presents a video on past and new in-vitro studies he has conducted on Prontosan®. The results of the in-vitro evidence show high antibiofilm activity of polyhexanide based antiseptics and lack or weak antibiofilm activity of hypochlorite-based antiseptic of total chlorine content equal to 80 parts per million. The results indicate that polyhexanide based antiseptics are highly useful in the treatment of biofilm, while hypochlorite-based antiseptics with low chlorine content may be applied for wound rinsing but not when specific antibiofilm activity is required. The in-vitro evidence of Prontosan® demonstrates the superiority against hypochlorous acids
Would you like to know how effective your wound irrigation is against biofilm? Click here to watch the video on the latest in-vitro evidence of Prontosan®.